Startups
Proteintech are a global biotech company and a renowned centre of excellence for the manufacture and supply of quality antibodies and proteins to the life science research community. With offices in the US (Chicago), UK (Manchester) and China (Wuhan) Proteintech are always available to support your research.
Part of Proteintech's early vision was to make all of its own products, to the highest standards possible and to take complete responsibility for the quality. With an emphasis on developing antibodies from whole proteins, Proteintech provides researchers with unmatched reliability and reproducibility.
Part of Proteintech's early vision was to make all of its own products, to the highest standards possible and to take complete responsibility for the quality. With an emphasis on developing antibodies from whole proteins, Proteintech provides researchers with unmatched reliability and reproducibility.
Overview
Location
United States, Illinois, Rosemont
Employees
201-500
Phone
+1 312-455-8498
Founded date
2002
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 13, 2022 | Antibodies Market to Surpass US$ 608 Billion by 2032 amid Growing Investment in Vaccine and Novel Therapy Development | Antibodies Sales to Grow Three-Fold Registering Double-Digit Growth at 11.9% CAGR through 2022 & beyond /EIN News/ -- Seoul, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Fact.MR in its latest antobodies market report provides key trends and opport... |
| Oct 12, 2022 | Antibodies Market to Surpass US$ 608 Billion by 2032 amid Growing Investment in Vaccine and Novel Therapy Development | Seoul, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Fact.MR in its latest antobodies market report provides key trends and opportunities in terms of product type, application, and end user for the upcoming decade. The study also focuses on offering un... |
| Jun 15, 2022 | YCharOS adds Developmental Studies Hybridoma Bank (DSHB) to Industry Advisory Committee | YCharOS continues to expand Industry Advisory Committee and releases new open data Adding an academic partner shows the strength and flexibility of YCharOS’ open science framework.” — Dr. Aled EdwardsTORONTO, CANADA, June 15, 2022 /EINPress... |
| Mar 21, 2022 | YCharOS adds ABclonal Technology to Industry Advisory Committee | YCharOS continues to expand Industry Advisory Committee and releases new open data TORONTO, CANADA, March 21, 2022 /EINPresswire.com/ -- YCharOS Inc., an open science company with the mission of characterizing commercially available antibod... |
| Oct 14, 2021 | ImmunoPrecise Antibodies : Announces At-The-Market Facility of up to US$50 Million - Form 6-K | ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million VICTORIA, British Columbia, October 13, 2021, - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA), a leader in f... |
| Oct 14, 2021 | ImmunoPrecise Antibodies : Announces At-The-Market Facility of up to US$50 Million | IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA), a leader in full-service therapeutic antibody discovery and development, today announced that it has entered into an At-The-Market Distribution Agreeme... |
| Feb 25, 2021 | ChromoTek and Absolute Antibody Collaborate on Recombinant Engineered Antibodies | The Nanobody-IgG fusions showcase the power of antibody engineering to open up experimental possibilities and facilitate new avenues of research. MUNICH, Germany and REDCAR, UK (PRWEB) February 25, 2021 ChromoTek GmbH, part of Proteintech s... |
| Jan 28, 2014 | UPDATED: Third Rock backs $14M round for Igenica's cancer-fighting antibodies | The antibody upstart Igenica has rounded up $14 million in venture cash to move its lead drug into the clinic. The Column Group, 5AM Ventures, OrbiMed and Third Rock Ventures all participated in the round. Much of the money is being earmark... |
Reviews 0
FAQ about Proteintech Group
When was Proteintech Group founded?
Proteintech Group was founded in 2002.
What has the press written about Proteintech Group?
Parsers VC has collected 9 articles mentioning Proteintech Group, among them “Antibodies Market to Surpass US$ 608 Billion by 2032 amid Growing Investment in Vaccine and Novel Therapy Development” (Oct 13, 2022) and “Antibodies Market to Surpass US$ 608 Billion by 2032 amid Growing Investment in Vaccine and Novel Therapy Development” (Oct 12, 2022).
Is Proteintech Group still active?
Yes, Proteintech Group is active; its latest activity on Parsers VC dates from Oct 19, 2026.